Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
03/30/2011 | EP2300459A1 Novel phenylpyrazinones as kinase inhibitors |
03/30/2011 | EP2300458A1 Substituted 1-(diazinyl) pyrazole-4-yl-acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators |
03/30/2011 | EP2300457A1 Substituted pyrroles and methods of use |
03/30/2011 | EP2300456A1 Bicyclic compounds having activity at the cxcr4 receptor |
03/30/2011 | EP2300455A2 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl) - imidazo [1, 2-b] [1, 2, 4] triazin-2-yl] benzamide and processes related to preparing the same |
03/30/2011 | EP2300454A1 Novel Microbiocides |
03/30/2011 | EP2300453A1 3, 4 - substituted piperidine derivatives as renin inhibitors |
03/30/2011 | EP2300452A1 5-ý5-ý2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoylmethylamino¨-4-(4-fluoro-2-methylphenyl)¨-2-pyridinyl-2-alkyl-prolinamide as nk1 receptor antagonists |
03/30/2011 | EP2300443A1 Triazole derivatives useful for the treatment of diseases |
03/30/2011 | EP2300440A1 3,4-dihydropyrimidine trpa1 antagonists |
03/30/2011 | EP2300438A1 Imidazole derivatives useful as inhibitors of faah |
03/30/2011 | EP2300435A2 Heterocyclic compounds as factor ixa inhibitors |
03/30/2011 | EP2300430A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
03/30/2011 | EP2300428A1 Aminopyridine derivatives |
03/30/2011 | EP2300427A1 Urea compounds as gamma secretase modulators |
03/30/2011 | EP2300422A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists |
03/30/2011 | EP2300005A1 Small molecule inhibitors of botulinum neurotoxins |
03/30/2011 | EP2299824A1 Pyrazole derivatives useful as inhibitors of faah |
03/30/2011 | EP1924577B1 Substituted benzimidazoles and methods of preparation |
03/30/2011 | EP1838674B1 Heteroaryl sulfonamides and ccr2 |
03/30/2011 | EP1441719B1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors |
03/30/2011 | EP1277738B1 Condensed heteroaryl derivatives |
03/30/2011 | CN1966500B Quinoxaline derivative, preparation method and uses |
03/30/2011 | CN1898210B 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
03/30/2011 | CN1876664B Organometallic complex and organic electroluminescent device using the same |
03/30/2011 | CN101998951A Acylthiourea compound or salt thereof, and use thereof |
03/30/2011 | CN101993431A Method for synthesizing trifloxysulfuron |
03/30/2011 | CN101993416A Quinoline compound and preparation method thereof, medicament combination containing compound and application of compound |
03/30/2011 | CN101993415A Compound as Hedgehog path inhibitor, medicine composition containing same and application thereof |
03/30/2011 | CN101993409A Heterocyclic compound, organic light-emitting device containing polycyclic heteroaryl compounds |
03/30/2011 | CN101445483B Method for preparing pesticide |
03/30/2011 | CN101402598B Improved method for preparing 1-benzhydryl-3-aza ring butanol |
03/30/2011 | CN101133049B Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol |
03/30/2011 | CN101133027B Pyridine-2-carboxamide derivatives as mglur5 antagonists |
03/30/2011 | CN101121692B Synthesis method for alpha-carbonylamide compound |
03/29/2011 | US7915423 Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
03/29/2011 | US7915422 enantioselective catalytic oxidation of a prochiral sulfide for making esomeprazole, omeprazole or optically active salt form nexium, in presence of a chiral transition metal complex and solvent-free; proton pump inhibitors useful in the treatment of ulcers |
03/29/2011 | US7915294 Method of treating colorectal carcinoma |
03/29/2011 | US7915293 Carbocyclic and heterocyclic sulfonamide derivatives, e.g., N-(2-bromo-5-(trifluoromethoxy)phenyl)-3,5-dichloro-4-(2-chloro-4-nitrophenoxy)benzenesulfonamide and 4-(2-(trifluoromethyl)phenoxy)-1-(3-trifluoromethyl)phenylsulfonyl)piperidine; treating proliferative diseases |
03/29/2011 | US7915291 Hepatitis C virus inhibitors |
03/29/2011 | US7915288 1-aryl-4-substituted isoquinolines |
03/29/2011 | US7915287 Substituted heterocycles and methods of use |
03/29/2011 | US7915283 e.g. 1-[4-(1-Phenyl-1-(pyrazinyl)-methylene)-piperidin-1-yl]-2-(4-methoxy-7-pyrazinyl-6-azaindol-3-yl)-ethane-1,2-dione; viricides for prophylaxis of lympadenopathy associated virus; synergystic mixtures with immunomodulators |
03/29/2011 | US7915274 Nitrogen containing heterocyclic compounds and medicines containing the same |
03/29/2011 | US7915263 Aminopyridine derivatives having aurora A selective inhibitory action |
03/29/2011 | US7915261 Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound |
03/29/2011 | US7915260 Urotensin II receptor antagonists |
03/29/2011 | US7915253 4-[2,6-Dimethyl-4-(4-trifluoromethoxy-phenyl)-piperazine-1-sulfonyl]-indan-2-carboxylic acid; peroxisome proliferator activated receptors modulator; antidiabetic, antiinflammatory agent; obesity, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome, ischemia-associated organ injury |
03/29/2011 | US7915251 Alpha-helix mimetics and methods relating to the treatment of fibrosis |
03/29/2011 | US7914706 Charge transport compositions and electronic devices made with such compositions |
03/29/2011 | CA2543250C Process for the preparation of ccr-2 antagonist |
03/29/2011 | CA2497237C N-substituted-2-oxodihydropyridine derivatives |
03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
03/29/2011 | CA2469055C Aminotetralin derivatives as muscarinic receptor antagonists |
03/29/2011 | CA2468715C Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
03/29/2011 | CA2443672C Aryl and biaryl piperidines used as mch antagonists |
03/29/2011 | CA2400856C Imaging agents for diagnosis of parkinson's disease |
03/29/2011 | CA2299139C 4-phenyl-pyridine derivatives |
03/24/2011 | WO2011035332A1 Pyrrolidinone carboxamide derivatives as chemerin-r ( chemr23 ) modulators |
03/24/2011 | WO2011035110A2 Treatment for oxidative stress and/or hypertension |
03/24/2011 | WO2011034518A1 Hcv protease inhibitors |
03/24/2011 | WO2011034504A1 Solid forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and methods of making the same |
03/24/2011 | WO2011034078A1 Glycine compound |
03/24/2011 | WO2011033531A1 A reusable end-capped bipyridine compound useful for selective detection of cyanide anions and process for preparation thereof |
03/24/2011 | WO2011033468A1 Process for the preparation of a crystalline form of lenalidomid |
03/24/2011 | WO2011033307A1 Nilotinib dihydrochloride salt |
03/24/2011 | WO2011033099A1 Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia |
03/24/2011 | WO2011033045A1 Heterocyclic antiviral compounds |
03/24/2011 | WO2011033018A1 Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines |
03/24/2011 | WO2011032692A1 Process for preparing 3-[(4s)-8-bromo-1-methyl-6-(2-pyridinyl)-4h-imidazol[1,2-a][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process |
03/24/2011 | WO2011032474A1 Method for preparing halofuginone derivative |
03/24/2011 | WO2011032320A1 Novel alkene oxindole derivatives |
03/24/2011 | WO2011032291A1 Selective calcium channel modulators |
03/24/2011 | WO2011032277A1 Quinazolinone derivatives as viral polymerase inhibitors |
03/24/2011 | US20110071298 Processes and Intermediates |
03/24/2011 | US20110071291 Hydrazide compound and pesticidal use of the same |
03/24/2011 | US20110071289 Aminopyrazole amide derivative |
03/24/2011 | US20110071286 Novel preparation process |
03/24/2011 | US20110071195 Novel alkene oxindole derivatives |
03/24/2011 | US20110071194 Chemical Compounds 572 |
03/24/2011 | US20110071192 Therapeutic Agents Useful for Treating Pain |
03/24/2011 | US20110071191 Insecticidal compounds |
03/24/2011 | US20110071190 Biphenyl compounds useful as muscarinic receptor antagonists |
03/24/2011 | US20110071165 Aza- and polyazanthranyl amides and their use as medicaments |
03/24/2011 | US20110071159 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament |
03/24/2011 | US20110071158 New compounds |
03/24/2011 | US20110071156 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
03/24/2011 | US20110071153 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors |
03/24/2011 | US20110071152 5-membered heterocycle-based p38 kinase inhibitors |
03/24/2011 | US20110071150 Indole derivatives as crac modulators |
03/24/2011 | US20110071149 Selective kinase inhibitors |
03/24/2011 | US20110071148 Compounds as the estrogen related receptors modulators and the uses thereof |
03/24/2011 | US20110071145 Raf Modulators And Methods Of Use |
03/24/2011 | US20110071144 Quinazoline derivatives and pharmaceutical compositions containing them |
03/24/2011 | US20110071134 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases |
03/24/2011 | US20110071132 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof |
03/24/2011 | US20110071131 Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands |
03/24/2011 | US20110071130 2-aminobenzimidazoles for treating neurodegenerative diseases |
03/24/2011 | US20110071126 Inhibitors of beta-secretase |
03/24/2011 | US20110071113 Thiazole Derivatives and Use Thereof |